Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,466 | 31,626 | 53,102 | 52,553 | 64,168 |
| Receivables | 67,199 | 69,013 | 61,556 | 55,284 | 57,487 |
| Other current assets | 31,129 | 24,449 | 21,108 | 21,158 | 20,153 |
| TOTAL | $137,977 | $127,465 | $137,968 | $131,150 | $155,536 |
| Non-Current Assets | |||||
| PPE Net | 1,787,041 | 1,796,552 | 1,751,966 | 1,748,885 | 1,741,632 |
| Investments And Advances | 69,705 | 78,066 | 84,097 | 82,210 | 83,180 |
| Intangibles | 26,032 | 26,342 | 13,814 | 4,128 | 4,203 |
| Other Non-Current Assets | 6,447 | 6,702 | 6,957 | 7,212 | 7,467 |
| TOTAL | $1,889,225 | $1,907,662 | $1,856,834 | $1,842,435 | $1,836,482 |
| Total Assets | $2,027,202 | $2,035,127 | $1,994,802 | $1,973,585 | $1,992,018 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 99,751 | 89,159 | 114,533 | 169,249 | 133,809 |
| Accounts payable and accrued liabilities | 43,441 | 42,104 | 34,007 | 28,664 | 40,771 |
| Accrued Expenses | 12,623 | 10,135 | 5,205 | 4,813 | 8,335 |
| TOTAL | $168,826 | $153,483 | $167,129 | $214,716 | $192,351 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,343,276 | 1,360,574 | 1,313,548 | 1,250,560 | 1,280,112 |
| Deferred Revenues | 13,011 | 12,085 | 13,384 | 11,990 | 9,404 |
| Other Non-Current Liabilities | 3,500 | 3,497 | 1,966 | -38 | -26 |
| TOTAL | $1,399,357 | $1,415,701 | $1,363,852 | $1,298,764 | $1,323,989 |
| Total Liabilities | $1,568,183 | $1,569,184 | $1,530,981 | $1,513,480 | $1,516,340 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,057 | 19,257 | 19,429 | 19,922 | 20,222 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 325,243 | 330,658 | 326,901 | 318,579 | 332,317 |
| Other shareholders' equity | -6,875 | -7,012 | -6,043 | -6,999 | -6,529 |
| TOTAL | $459,019 | $465,943 | $463,821 | $460,105 | $475,678 |
| Total Liabilities And Equity | $2,027,202 | $2,035,127 | $1,994,802 | $1,973,585 | $1,992,018 |